SynthesisFrontiers in immunology2025

Efficacy and safety of PARP inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis.

Huanhuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.